Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142.
暂无分享，去创建一个
B. Neyns | S. Kopetz | M. Overman | M. Aglietta | M. Morse | R. McDermott | R. Moss | T. André | E. Cutsem | F. Gelsomino | F. Bergamo | S. Kamble | A. Hendlisz | Franklin L. Chen | M. Wong | Z. Cao | Huanyu Zhao